Idi na sadržaj

Hematologija

Anemija zbog manjka željeza

Risks for anaphylaxis with intravenous iron formulations: a retrospective cohort study. (otvara se novi prozor)

Dave CV, Brittenham GM, Carson JL, Setoguchi S

Izvor‎: Ann Intern Med. 2022;175(5):656-64.

Indeks‎: PubMed 35344378

DOI‎: 10.7326/M21-4009

https://pubmed.ncbi.nlm.nih.gov/35344378/ (otvara se novi prozor)

Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. (otvara se novi prozor)

Lim W, Afif W, Knowles S, Lim G, Lin Y, Mothersill C, Nistor I, Rehman F, Song C, Xenodemetropoulos T

Izvor‎: Vox Sang 2019;114(4):363-73.

Indeks‎: PubMed 30937914

DOI‎: 10.1111/vox.12773

https://www.ncbi.nlm.nih.gov/pubmed/30937914 (otvara se novi prozor)

Intravenous iron in patients undergoing maintenance hemodialysis. (otvara se novi prozor)

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I; PIVOTAL Investigators and Committees

Izvor‎: N Engl J Med 2019;380(5):447-58.

Indeks‎: PubMed 30365356

DOI‎: 10.1056/NEJMoa1810742

https://www.ncbi.nlm.nih.gov/pubmed/30365356 (otvara se novi prozor)